Table 1 Clinicopathological characteristics of patient samples and expression of ZAP in bladder cancer patients and correlation between ZAP expression and Clinicopathological characteristics of bladder cancer patients
Characteristics | Â | Total (n=90) | ZAP expression | Chi-square test p-value | |
|---|---|---|---|---|---|
| Â | Â | Â | Low expression (45.6%) | Normal expression (54.4%) | Â |
Gender | Female | 14 | 5 (35.7%) | 9 (64.3%) | 0.421 |
Male | 76 | 36 (47.4%) | 40 (52.6%) | Â | |
Age (years) | ≤70 | 48 | 21 (43.8%) | 27 (56.2%) | 0.7131 |
>70 | 42 | 20 (47.6%) | 22 (52.4%) | Â | |
Anatomic stage | 0is | 5 | 1 (20.0%) | 4 (80.0%) | 0.0037 |
I | 6 | 1 (16.7%) | 5 (83.3%) | Â | |
II | 24 | 5 (20.8%) | 19 (79.2%) | Â | |
III | 37 | 24 (64.9%) | 13 (35.1%) | Â | |
IV | 18 | 10 (55.6%) | 8 (44.4%) | Â | |
T classification | Tis | 5 | 1 (20.0%) | 4 (80.0%) | 0.0024 |
T1 | 9 | 1 (11.1%) | 8 (88.9%) | Â | |
T2 | 24 | 6 (25.0%) | 18 (75.0%) | Â | |
T3 | 43 | 27 (62.8%) | 16 (37.2%) | Â | |
T4 | 9 | 6 (66.7%) | 3 (33.3%) | Â | |
Node invasion | No | 72 | 31 (43.1%) | 41 (56.9%) | 0.3409 |
Yes | 18 | 10 (55.6%) | 8 (44.4%) | Â | |
